PD-1 blockade therapy enhances the antitumor effects of lymphodepletion and adoptive T cell transfer

被引：0
|
作者：
Watanabe, Satoshi
Takahashi, Miho
Suzuki, Ryo
Arita, Masashi
Sato, Ko
Fujisaki, Toshiya
Ohtsubo, Aya
Shoji, Satoshi
Shono, Kunihiro
Masuda, Takaaki
Sekiya, Tomoki
Nozaki, Koichiro
Tanaka, Tomohiro
Kondo, Rie
Saida, Yu
Hokari, Satoshi
Koya, Toshiyuki
Kikuchi, Toshiaki
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4064
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4064
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Combination Therapy with iRGD-antiCD3 and PD-1 Blockade Enhances Antitumor Potency of Cord Blood-Derived T Cells
    Zhu, Mei
    Wang, Hongmei
    Zhou, Shujuan
    Wei, Jia
    Ding, Naiqing
    Shao, Jie
    Yu, Lixia
    Feng, Zhenqing
    Liu, Baorui
    ONCOTARGETS AND THERAPY, 2021, 14 : 835 - 844
  • [22] Inducible Regulatory T Cell Predicts Efficacy of PD-1 Blockade Therapy in Melanoma
    Shen, Lujun
    Wu, Ying
    Qi, Han
    Jiang, Yiquan
    Jin, Jietian
    Cao, Fei
    Chen, Shuanggang
    Yang, Yuanzhong
    Huang, Tao
    Song, Ze
    Chen, Qifeng
    Zhang, Yinqi
    Mo, Jinqing
    Li, Dandan
    Zhang, Xiaoshi
    Fan, Weijun
    ADVANCED THERAPEUTICS, 2022, 5 (04)
  • [23] PD-1 blockade therapy for cancer
    Ribas, Antoni
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10)
  • [24] PD-1 blockade and T cell responses in merkel cell carcinoma
    Miller, N. J.
    Church, C.
    Fling, S.
    Kulikauskas, R.
    Ramchurren, N.
    Shinohara, M.
    Cheever, M.
    Topalian, S. L.
    Nghiem, P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S45 - S45
  • [25] PD-1 and impaired antitumor T cell responses in melanoma
    不详
    IMMUNOTHERAPY, 2009, 1 (06) : 924 - 924
  • [26] Blockade of TIM-3 and PD-1 enhances the antitumor effects of MAGE-A11 antigen- specific cytotoxic T lymphocytes
    Zhang, Jiandong
    Zhang, Fengxia
    Wu, Hua
    Zhang, Bei
    Zhang, Xiaoming
    Wu, Xiangyun
    BULLETIN DU CANCER, 2022, 109 (09) : 895 - 908
  • [27] Combination therapy with T cell engager and PD-L1 blockade enhances the antitumor potency of T cells as predicted by a QSP model
    Ma, Huilin
    Wang, Hanwen
    Sove, Richard J.
    Wang, Jun
    Giragossian, Craig
    Popel, Aleksander S.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [28] PD-1 Blockade Enhances Radiation Therapy-Induced Abscopal Effect
    Park, S. S.
    Dong, H.
    Zhao, W.
    Grams, M. P.
    Liu, X.
    Harrington, S. M.
    Furutani, K. M.
    Krco, C. J.
    Olivier, K. R.
    Markovic, S. N.
    Kwon, E. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S57 - S58
  • [29] Current status and future prospects of the strategy of combining CAR-T with PD-1 blockade for antitumor therapy
    Xu, Jinjing
    Zhang, Qing
    Tian, Kang
    Wang, Haiyu
    Yin, Hong
    Zheng, Junnian
    MOLECULAR MEDICINE REPORTS, 2018, 17 (02) : 2083 - 2088
  • [30] Enhancement of PSMA-Directed Car Adoptive T Cells by PD-1/PD-L1 Blockade
    Serganova, Inna
    Moroz, Ekaterina
    Cohen, Ivan
    Moroz, Maxim
    Mane, Mayuresh
    Zurita, Juan
    Shenker, Larissa
    Ponomarev, Vladimir
    Blasberg, Ronald
    MOLECULAR THERAPY, 2017, 25 (05) : 253 - 253
12345